Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Stereotactic Re-irradiation for Local Recurrence in the Prostatic Bed After Prostatectomy: Preliminary Results.

Olivier J, Basson L, Puech P, Lacornerie T, Villers A, Wallet J, Lartigau E, Pasquier D.

Front Oncol. 2019 Feb 15;9:71. doi: 10.3389/fonc.2019.00071. eCollection 2019.

2.

Reirradiation for isolated local recurrence of prostate cancer: Mono-institutional series of 64 patients treated with salvage stereotactic body radiotherapy (SBRT).

Jereczek-Fossa BA, Rojas DP, Zerini D, Fodor C, Viola A, Fanetti G, Volpe S, Luraschi R, Bazani A, Rondi E, Cattani F, Vavassori A, Garibaldi C, Alessi S, Pricolo P, Petralia G, Cozzi G, De Cobelli O, Musi G, Orecchia R, Marvaso G, Ciardo D.

Br J Radiol. 2019 Feb;92(1094):20180494. doi: 10.1259/bjr.20180494. Epub 2018 Nov 9.

PMID:
30379566
3.

Stereotactic body re-irradiation therapy for locally recurrent prostate cancer after external-beam radiation therapy: Initial report.

Janoray G, Reynaud-Bougnoux A, Ruffier-Loubière A, Bernadou G, Pointreau Y, Calais G.

Cancer Radiother. 2016 Jun;20(4):275-81. doi: 10.1016/j.canrad.2016.03.005. Epub 2016 Jun 21.

PMID:
27342944
4.

Salvage prostate re-irradiation using high-dose-rate brachytherapy or focal stereotactic body radiotherapy for local recurrence after definitive radiation therapy.

Mbeutcha A, Chauveinc L, Bondiau PY, Chand ME, Durand M, Chevallier D, Amiel J, Kee DL, Hannoun-Lévi JM.

Radiat Oncol. 2017 Mar 9;12(1):49. doi: 10.1186/s13014-017-0789-9.

5.

Salvage robotic SBRT for local prostate cancer recurrence after radiotherapy: preliminary results of the Oscar Lambret Center.

Leroy T, Lacornerie T, Bogart E, Nickers P, Lartigau E, Pasquier D.

Radiat Oncol. 2017 Jun 9;12(1):95. doi: 10.1186/s13014-017-0833-9.

6.

High-Dose Robotic Stereotactic Body Radiotherapy in the Treatment of Patients With Prostate Cancer: Preliminary Results in 26 Patients.

Pontoriero A, Iatì G, Mondello S, Midili F, Siragusa C, Brogna A, Ielo I, Anastasi G, Magno C, Pergolizzi S, De Renzis C.

Technol Cancer Res Treat. 2016 Feb;15(1):179-85. doi: 10.1177/1533034614566994. Epub 2015 Jan 13.

PMID:
25586517
7.

A single-center study of 100 consecutive patients with localized prostate cancer treated with stereotactic body radiotherapy.

Bolzicco G, Favretto MS, Satariano N, Scremin E, Tambone C, Tasca A.

BMC Urol. 2013 Oct 17;13:49. doi: 10.1186/1471-2490-13-49.

8.

CyberKnife stereotactic radiotherapy for isolated recurrence in the prostatic bed.

Detti B, Bonomo P, Masi L, Doro R, Cipressi S, Iermano C, Bonucci I, Franceschini D, Di Brina L, Baki M, Simontacchi G, Meattini I, Carini M, Serni S, Nicita G, Livi L.

World J Urol. 2016 Mar;34(3):311-7. doi: 10.1007/s00345-015-1613-5. Epub 2015 Jun 11.

PMID:
26062525
9.

Prostate-specific antigen doubling time subsequent to radical prostatectomy is a predictor of outcome following salvage external beam radiation therapy: a single-centre experience.

Servoll E, Sæter T, Vlatkovic L, Nesland JM, Waaler G, Axcrona K.

Scand J Urol. 2015 Jun;49(3):218-23. doi: 10.3109/21681805.2014.982168. Epub 2014 Nov 27.

PMID:
25428750
10.

Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.

Vargas C, Kestin LL, Weed DW, Krauss D, Vicini FA, Martinez AA.

Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):714-24.

PMID:
15708249
11.

Salvage of locally recurrent prostate cancer after external beam radiation using reduced-dose brachytherapy with neoadjuvant plus adjuvant androgen deprivation.

Baumann BC, Baumann JC, Christodouleas JP, Soffen E.

Brachytherapy. 2017 Mar - Apr;16(2):291-298. doi: 10.1016/j.brachy.2016.12.011. Epub 2017 Jan 27.

PMID:
28139422
12.

High-dose-rate stereotactic body radiation therapy for postradiation therapy locally recurrent prostatic carcinoma: Preliminary prostate-specific antigen response, disease-free survival, and toxicity assessment.

Fuller DB, Wurzer J, Shirazi R, Bridge SS, Law J, Mardirossian G.

Pract Radiat Oncol. 2015 Nov-Dec;5(6):e615-23. doi: 10.1016/j.prro.2015.04.009. Epub 2015 Jun 6.

PMID:
26059509
13.

Stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience.

Chen LN, Suy S, Uhm S, Oermann EK, Ju AW, Chen V, Hanscom HN, Laing S, Kim JS, Lei S, Batipps GP, Kowalczyk K, Bandi G, Pahira J, McGeagh KG, Collins BT, Krishnan P, Dawson NA, Taylor KL, Dritschilo A, Lynch JH, Collins SP.

Radiat Oncol. 2013 Mar 13;8:58. doi: 10.1186/1748-717X-8-58.

14.

Salvage image-guided intensity modulated or stereotactic body reirradiation of local recurrence of prostate cancer.

Zerini D, Jereczek-Fossa BA, Fodor C, Bazzani F, Maucieri A, Ronchi S, Ferrario S, Colangione SP, Gerardi MA, Caputo M, Cecconi A, Gherardi F, Vavassori A, Comi S, Cambria R, Garibaldi C, Cattani F, De Cobelli O, Orecchia R.

Br J Radiol. 2015 Aug;88(1052):20150197. doi: 10.1259/bjr.20150197. Epub 2015 Jun 9.

15.

Re-irradiation with stereotactic body radiation therapy as a novel treatment option for isolated local recurrence of pancreatic cancer after multimodality therapy: experience from two institutions.

Wild AT, Hiniker SM, Chang DT, Tran PT, Khashab MA, Limaye MR, Laheru DA, Le DT, Kumar R, Pai JS, Hargens B, Sharabi AB, Shin EJ, Zheng L, Pawlik TM, Wolfgang CL, Koong AC, Herman JM.

J Gastrointest Oncol. 2013 Dec;4(4):343-51. doi: 10.3978/j.issn.2078-6891.2013.044.

16.

Outcome after PSMA PET/CT based salvage radiotherapy in patients with biochemical recurrence after radical prostatectomy: a bi-institutional retrospective analysis.

Schmidt-Hegemann NS, Stief C, Kim TH, Eze C, Kirste S, Strouthos I, Li M, Schultze-Seemann W, Ilhan H, Fendler WP, Bartenstein P, Grosu AL, Ganswindt U, Belka C, Meyer PT, Zamboglou C.

J Nucl Med. 2018 Jul 12. pii: jnumed.118.212563. doi: 10.2967/jnumed.118.212563. [Epub ahead of print]

PMID:
30002108
17.

EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.

Heidenreich A, Bastian PJ, Bellmunt J, Bolla M, Joniau S, van der Kwast T, Mason M, Matveev V, Wiegel T, Zattoni F, Mottet N; European Association of Urology.

Eur Urol. 2014 Feb;65(2):467-79. doi: 10.1016/j.eururo.2013.11.002. Epub 2013 Nov 12. Review.

PMID:
24321502
18.

Salvage high-dose-rate brachytherapy for histologically confirmed macroscopic local relapsed prostate cancer after radical prostatectomy.

Buchser D, Gomez-Iturriaga A, Melcon JI, Casquero F, Llarena R, Cacicedo J, Bilbao P.

J Contemp Brachytherapy. 2016 Dec;8(6):477-483. doi: 10.5114/jcb.2016.64441. Epub 2016 Dec 6.

20.

Salvage radiotherapy for biochemical and clinical failures following radical prostatectomy.

Do T, Parker RG, Do C, Tran L, Do L, Dolkar D.

Cancer J Sci Am. 1998 Sep-Oct;4(5):324-30.

PMID:
9815297

Supplemental Content

Support Center